A dual-mechanism model of Selinexor in DLBCL: p53 reactivation and metabolic reprogramming
Selinexor治疗弥漫性大B细胞淋巴瘤的双重机制模型:p53再激活和代谢重编程
期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-026-08014-3
Zhang, Wenqi; Shi, Lin; Li, Yan; He, Cuiying; Cui, Shuixin; Liu, Yueping; Wang, Xiaoxiao; Liu, Lihong; Gao, Yuhuan; Diao, Lanping; Wu, Lili; Yao, Yingzhen; Feng, Yi; Wu, Xiaolin; Yin, Shaoning; Li, Weijing; Song, Boning; Huang, Chen